Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the launch of its completely redesigned Web site: www.ligand.com. The new Web site is designed as a comprehensive resource for investors, prospective corporate partners and the life science community to learn more about Ligand's business model, robust pipeline, high-profile partnerships and innovative technology.
“Our significant developments in the past three years, including restructured operations, multiple acquisitions and drug approvals, have broadened and deepened the Ligand story. This new site provides visitors an architecture that facilitates quick and efficient access to the information they need”
"Our significant developments in the past three years, including restructured operations, multiple acquisitions and drug approvals, have broadened and deepened the Ligand story. This new site provides visitors an architecture that facilitates quick and efficient access to the information they need," said John L. Higgins, President and Chief Executive Officer of Ligand Pharmaceuticals.
Obesity crisis in the U.S. expected to worsen by 2050